Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group

Transplant Proc. 1995 Feb;27(1):45-9.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Antilymphocyte Serum
  • Azathioprine / therapeutic use
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control*
  • Graft Survival
  • Humans
  • Incidence
  • Liver Diseases / surgery
  • Liver Neoplasms / surgery
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Liver Transplantation / physiology
  • Male
  • Steroids / therapeutic use
  • Survival Rate
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*

Substances

  • Antilymphocyte Serum
  • Steroids
  • Cyclosporine
  • Azathioprine
  • Tacrolimus